Trifolium Biotech-B (02197) reports a profit growth, with expected mid-term net profit of approximately 957 million to 1.204 billion yuan, turning loss into profit year-on-year.

Zhimedia Financial News App, Trifolium Biotech-B (02197) announced that the group expects to record a net profit of approximately 957 million to 1.204 billion yuan for the six months ending June 30, 2026, while in the same period last year, a net loss of approximately 101.3 million yuan was recorded.